Literature DB >> 19911248

Duration of untreated illness and suicide in bipolar disorder: a naturalistic study.

A Carlo Altamura1, Bernardo Dell'Osso, Heather A Berlin, Massimiliano Buoli, Roberta Bassetti, Emanuela Mundo.   

Abstract

The aim of this naturalistic study was to evaluate the potential influence of the duration of untreated illness (DUI)--defined as the time elapsed between the occurrence of the first mood episode and the first adequate pharmacological treatment with mood stabilizers--on the clinical course of bipolar disorder (BD). Three hundred and twenty outpatients (n = 320) with a DSM-IV diagnosis of BD--either Type I or Type II--were interviewed; their clinical features were collected and they were naturalistically followed-up for 5 years. At the end of the follow-up observation, the sample was subdivided into two groups: one group with a DUI < or =2 years (n = 65) and another group with a DUI >2 years (n = 255). The main demographic and clinical variables were analyzed and compared between the two subgroups of patients using chi-square tests for dichotomous variables or Mann-Whitney U tests for continuous variables. Patients with a longer DUI showed a higher frequency of suicide attempts (Z = -2.11, P = 0.035), a higher number of suicide attempters (chi(2) = 4.13, df = 1, P = 0.04), and a longer duration of illness (Z = -6.79, P < 0.0001) when compared to patients with a shorter DUI. Moreover, patients with a longer DUI had a depressive first episode more frequently than patients with a shorter DUI (chi(2) = 11.28, df = 2, P = 0.004). A further analysis performed dividing the total sample into two subgroups on the basis of a DUI of 6 years (corresponding to the median value of the DUI in the study sample) confirmed prior findings. Results indicate a potential association between a longer DUI and a worse outcome in BD, particularly in terms of suicidality, and confirm the clinical relevance of early diagnosis and pharmacological intervention with mood stabilizers in BD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19911248     DOI: 10.1007/s00406-009-0085-2

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  24 in total

1.  Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study.

Authors:  A C Altamura; R Bassetti; F Sassella; D Salvadori; E Mundo
Journal:  Schizophr Res       Date:  2001-10-01       Impact factor: 4.939

Review 2.  Prophylaxis latency and outcome in bipolar disorders.

Authors:  Christopher Baethge; Leonardo Tondo; Irene M Bratti; Tom Bschor; Michael Bauer; Adele C Viguera; Ross J Baldessarini
Journal:  Can J Psychiatry       Date:  2003-08       Impact factor: 4.356

3.  Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorder.

Authors:  Christopher Baethge; Philipp Gruschka; Michael N Smolka; Anne Berghöfer; Tom Bschor; Bruno Müller-Oerlinghausen; Michael Bauer
Journal:  J Psychiatry Neurosci       Date:  2003-09       Impact factor: 6.186

4.  Early age at onset of bipolar disorder is associated with more severe clinical features but delayed treatment seeking.

Authors:  Kirsi Suominen; Outi Mantere; Hanna Valtonen; Petri Arvilommi; Sami Leppämäki; Tiina Paunio; Erkki Isometsä
Journal:  Bipolar Disord       Date:  2007-11       Impact factor: 6.744

5.  Does treatment delay in first-episode psychosis really matter?

Authors:  S M Harrigan; P D McGorry; H Krstev
Journal:  Psychol Med       Date:  2003-01       Impact factor: 7.723

6.  Is bipolar I disorder heterogeneous?

Authors:  Jules Angst; Regina Gerber-Werder; Hans-Ulrich Zuberbühler; Alex Gamma
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-04       Impact factor: 5.270

7.  Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder.

Authors:  Joseph F Goldberg; Carrie L Ernst
Journal:  J Clin Psychiatry       Date:  2002-11       Impact factor: 4.384

Review 8.  Suicidal behaviour in bipolar disorder: risk and prevention.

Authors:  Leonardo Tondo; Göran Isacsson; Ross Baldessarini
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

9.  White matter hyperintensities and their associations with suicidality in patients with major affective disorders.

Authors:  Maurizio Pompili; Stefan Ehrlich; Eleonora De Pisa; J John Mann; Marco Innamorati; Andrea Cittadini; Benedetta Montagna; Paolo Iliceto; Andrea Romano; Mario Amore; Roberto Tatarelli; Paolo Girardi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-09-27       Impact factor: 5.270

10.  Clinical variables related to suicide attempts in schizophrenic patients: a retrospective study.

Authors:  A C Altamura; R Bassetti; S Bignotti; R Pioli; E Mundo
Journal:  Schizophr Res       Date:  2003-03-01       Impact factor: 4.939

View more
  48 in total

1.  Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder.

Authors:  Alessandro Serretti; Alberto Chiesa; Raffaella Calati; Sylvie Linotte; Othman Sentissi; Konstantinos Papageorgiou; Siegfried Kasper; Joseph Zohar; Diana De Ronchi; Julien Mendlewicz; Daniela Amital; Stuart Montgomery; Daniel Souery
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-05-09       Impact factor: 5.270

2.  An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.

Authors:  A Carlo Altamura; Marta Serati; Alessandra Albano; Riccardo A Paoli; Ira D Glick; Bernardo Dell'Osso
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-02-18       Impact factor: 5.270

3.  Internet suicide searches and the incidence of suicide in young people in Japan.

Authors:  Akihito Hagihara; Shogo Miyazaki; Takeru Abe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-04-21       Impact factor: 5.270

Review 4.  Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder.

Authors:  Ayal Schaffer; Erkki T Isometsä; Leonardo Tondo; Doris H Moreno; Mark Sinyor; Lars Vedel Kessing; Gustavo Turecki; Abraham Weizman; Jean-Michel Azorin; Kyooseob Ha; Catherine Reis; Frederick Cassidy; Tina Goldstein; Zoltán Rihmer; Annette Beautrais; Yuan-Hwa Chou; Nancy Diazgranados; Anthony J Levitt; Carlos A Zarate; Lakshmi Yatham
Journal:  Aust N Z J Psychiatry       Date:  2015-07-16       Impact factor: 5.744

5.  Suicide risk around the world: a meta-analysis of longitudinal studies.

Authors:  E M Guzmán; C B Cha; J D Ribeiro; J C Franklin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-09-04       Impact factor: 4.328

6.  Factors associated with delayed diagnosis of mood and/or anxiety disorders.

Authors:  Ricky Cheung; Siobhan O'Donnell; Nawaf Madi; Elliot Goldner
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-05       Impact factor: 3.240

7.  Twin studies for the investigation of the relationships between genetic factors and brain abnormalities in bipolar disorder.

Authors:  L Squarcina; C Fagnani; M Bellani; C A Altamura; P Brambilla
Journal:  Epidemiol Psychiatr Sci       Date:  2016-09-19       Impact factor: 6.892

8.  Affective disorders: the role of the duration of untreated illness, suicidality and pharmacogenetics.

Authors:  P Falkai; H-J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-08       Impact factor: 5.270

Review 9.  Meta-analysis of the Interval between the Onset and Management of Bipolar Disorder.

Authors:  Jessica Dagani; Giulia Signorini; Olav Nielssen; Moira Bani; Adriana Pastore; Giovanni de Girolamo; Matthew Large
Journal:  Can J Psychiatry       Date:  2016-07-11       Impact factor: 4.356

10.  Reexamining associations between mania, depression, anxiety and substance use disorders: results from a prospective national cohort.

Authors:  M Olfson; R Mojtabai; K R Merikangas; W M Compton; S Wang; B F Grant; C Blanco
Journal:  Mol Psychiatry       Date:  2016-05-03       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.